1. Home
  2. AZTR vs LIPO Comparison

AZTR vs LIPO Comparison

Compare AZTR & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • LIPO
  • Stock Information
  • Founded
  • AZTR 2014
  • LIPO 2005
  • Country
  • AZTR United States
  • LIPO United States
  • Employees
  • AZTR N/A
  • LIPO N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • LIPO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AZTR Health Care
  • LIPO Health Care
  • Exchange
  • AZTR Nasdaq
  • LIPO Nasdaq
  • Market Cap
  • AZTR 4.0M
  • LIPO 3.2M
  • IPO Year
  • AZTR 2023
  • LIPO 2022
  • Fundamental
  • Price
  • AZTR $0.45
  • LIPO $2.43
  • Analyst Decision
  • AZTR
  • LIPO Strong Buy
  • Analyst Count
  • AZTR 0
  • LIPO 1
  • Target Price
  • AZTR N/A
  • LIPO $2.00
  • AVG Volume (30 Days)
  • AZTR 187.3K
  • LIPO 132.1K
  • Earning Date
  • AZTR 11-12-2024
  • LIPO 11-26-2024
  • Dividend Yield
  • AZTR N/A
  • LIPO N/A
  • EPS Growth
  • AZTR N/A
  • LIPO N/A
  • EPS
  • AZTR N/A
  • LIPO N/A
  • Revenue
  • AZTR $97,500.00
  • LIPO $483,533.00
  • Revenue This Year
  • AZTR $494.75
  • LIPO N/A
  • Revenue Next Year
  • AZTR N/A
  • LIPO N/A
  • P/E Ratio
  • AZTR N/A
  • LIPO N/A
  • Revenue Growth
  • AZTR N/A
  • LIPO 0.78
  • 52 Week Low
  • AZTR $0.43
  • LIPO $2.21
  • 52 Week High
  • AZTR $68.40
  • LIPO $12.00
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 33.29
  • LIPO 36.24
  • Support Level
  • AZTR $0.43
  • LIPO $2.24
  • Resistance Level
  • AZTR $0.60
  • LIPO $3.48
  • Average True Range (ATR)
  • AZTR 0.05
  • LIPO 0.37
  • MACD
  • AZTR -0.00
  • LIPO -0.05
  • Stochastic Oscillator
  • AZTR 8.93
  • LIPO 17.09

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About LIPO Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.

Share on Social Networks: